Mankind Pharma Limited (NSE:MANKIND)
India flag India · Delayed Price · Currency is INR
2,638.60
-21.40 (-0.80%)
Nov 12, 2026, 3:29 PM IST

Mankind Pharma Stock Forecast

Stock Price Forecast

According to 19 analysts polled by S&P Global, Mankind Pharma stock has a consensus rating of "Buy" and an average price target of ₹2,703. The average 1-year stock price forecast is 2.45% higher than the current stock price, while the lowest is ₹2,057 (-22.04%) and the highest is ₹3,280 (+24.31%).

Price Target: ₹2,703 (+2.45%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₹2,057₹2,703₹2,660₹3,280
Change-22.04%+2.45%+0.81%+24.31%

Analyst Ratings

The average analyst rating for Mankind Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy765566
Buy897766
Hold113333
Sell333332
Strong Sell111111
Total202019191918

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jefferies
Jefferies
Buy
Maintains
₹3,220 → ₹2,900
BuyMaintains₹3,220 → ₹2,900+9.91%Oct 30, 2026
Bernstein
Bernstein
Sell
Maintains
₹2,057
SellMaintains₹2,057-22.04%Oct 26, 2026
Unknown Analyst
Kotak Mahindra
No rating
Kotak Mahindra
Buy
Maintains
₹3,000
BuyMaintains₹3,000+13.70%Sep 22, 2026
J.P. Morgan
J.P. Morgan
Hold
Downgrades
₹2,700
HoldDowngrades₹2,700+2.33%Aug 4, 2026
Geojit Research
Geojit Research
Buy
Maintains
₹2,600 → ₹2,660
BuyMaintains₹2,600 → ₹2,660+0.81%Jun 16, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
163.09B
from 142.78B
Increased by 14.23%
Revenue Next Year
182.92B
from 163.09B
Increased by 12.16%
EPS This Year
58.88
from 51.96
Increased by 13.31%
EPS Next Year
71.77
from 58.88
Increased by 21.89%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
77.82B87.49B102.60B122.07B142.78B163.09B
Revenue Growth
25.22%12.44%17.27%18.98%16.96%14.23%
Gross Profit
52.94B57.46B69.55B85.40B100.13B117.73B
Gross Margin
68.03%65.68%67.78%69.96%70.13%72.19%
Operating Income
18.32B15.88B21.50B25.08B28.19B33.55B
Net Income
14.33B12.82B19.13B19.91B19.13B24.27B
EPS
----51.9658.88
EPS Growth
----5.87%13.31%
Forward PE
--43.8845.1335.5444.81
Free Cash Flow
----23.87B22.40B
No. Analysts
-----19
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue202720282029
High165.7B
Avg163.1B
Low159.2B

Revenue Growth

Revenue Growth202720282029
High
16.0%
Avg
14.2%
Low
11.5%

EPS Forecast

EPS202720282029
High62.00
Avg58.88
Low53.66

EPS Growth

EPS Growth202720282029
High
19.3%
Avg
13.3%
Low
3.3%